During the past decade, Liver Center of Atlanta conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Liver Center of Atlanta" are "Hepatitis C" (1 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "Liver Center of Atlanta" in a lesser frequency.

Most popular intervention types in "Liver Center of Atlanta" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "CTS-1027" (1 trials), "Copegus®" (1 trials), "GS-9451" (1 trials), "GS-9451 placebo" (1 trials) and "Pegasys®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Liver Center of Atlanta" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Liver Center of Atlanta". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Liver Center of Atlanta, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Liver Center of Atlanta, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".